Report Detail
Global (United States, European Union and China) Anal Cancer Market Research Report 2019-2025
- RnM3704791 |
- 28 August, 2019 |
- Global |
- 127 Pages |
- QYResearch |
- Pharma & Healthcare
Anal cancer is a disease in which malignant (cancer) cells form in the tissues of the anus. Being infected with the human papillomavirus (HPV) increases the risk of developinganal cancer. Signs of anal cancer include bleeding from theanus or rectum or a lump near the anus.
In 2019, the market size of Anal Cancer is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Anal Cancer.
This report studies the global market size of Anal Cancer, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Anal Cancer sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
GlaxoSmithKline
Spectrum Pharmaceuticals
Hospira
Global BioPharma
Advaxis
Amgen Inc
Atara Biotherapeutics
Bayer
Cell Medica
Eli Lilly
Genticel
ISA Pharmaceuticals
Merck＆Co
Millennium Pharmaceuticals
Novartis
Ono Pharmaceutical
Oryx
PDS Biotechnology
Sun Pharma
Market Segment by Product Type
Fluorouracil
Cisplatin
Carboplatin
Other
Market Segment by Application
Hospitals
Long-term care centers
Pharmacies
Other
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Anal Cancer status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Anal Cancer manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Anal Cancer are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Anal Cancer Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Fluorouracil
- 1.3.3 Cisplatin
- 1.3.4 Carboplatin
- 1.3.5 Other
- 1.4 Market Segment by Application
- 1.4.1 Global Anal Cancer Market Share by Application (2019-2025)
- 1.4.2 Hospitals
- 1.4.3 Long-term care centers
- 1.4.4 Pharmacies
- 1.4.5 Other
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Anal Cancer Market Size
- 2.1.1 Global Anal Cancer Revenue 2014-2025
- 2.1.2 Global Anal Cancer Sales 2014-2025
- 2.2 Anal Cancer Growth Rate by Regions
- 2.2.1 Global Anal Cancer Sales by Regions 2014-2019
- 2.2.2 Global Anal Cancer Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Anal Cancer Sales by Manufacturers
- 3.1.1 Anal Cancer Sales by Manufacturers 2014-2019
- 3.1.2 Anal Cancer Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Anal Cancer Revenue by Manufacturers (2014-2019)
- 3.2.2 Anal Cancer Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Anal Cancer Market Concentration Ratio (CR5 and HHI)
- 3.3 Anal Cancer Price by Manufacturers
- 3.4 Key Manufacturers Anal Cancer Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Anal Cancer Market
- 3.6 Key Manufacturers Anal Cancer Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Fluorouracil Sales and Revenue (2014-2019)
- 4.1.2 Cisplatin Sales and Revenue (2014-2019)
- 4.1.3 Carboplatin Sales and Revenue (2014-2019)
- 4.1.4 Other Sales and Revenue (2014-2019)
- 4.2 Global Anal Cancer Sales Market Share by Type
- 4.3 Global Anal Cancer Revenue Market Share by Type
- 4.4 Anal Cancer Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Anal Cancer Sales by Application
6 United States
- 6.1 United States Anal Cancer Breakdown Data by Company
- 6.2 United States Anal Cancer Breakdown Data by Type
- 6.3 United States Anal Cancer Breakdown Data by Application
7 European Union
- 7.1 European Union Anal Cancer Breakdown Data by Company
- 7.2 European Union Anal Cancer Breakdown Data by Type
- 7.3 European Union Anal Cancer Breakdown Data by Application
8 China
- 8.1 China Anal Cancer Breakdown Data by Company
- 8.2 China Anal Cancer Breakdown Data by Type
- 8.3 China Anal Cancer Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Anal Cancer Breakdown Data by Company
- 9.2 Rest of World Anal Cancer Breakdown Data by Type
- 9.3 Rest of World Anal Cancer Breakdown Data by Application
- 9.4 Rest of World Anal Cancer Breakdown Data by Countries
- 9.4.1 Rest of World Anal Cancer Sales by Countries
- 9.4.2 Rest of World Anal Cancer Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 GlaxoSmithKline
- 10.1.1 GlaxoSmithKline Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Anal Cancer
- 10.1.4 Anal Cancer Product Introduction
- 10.1.5 GlaxoSmithKline Recent Development
- 10.2 Spectrum Pharmaceuticals
- 10.2.1 Spectrum Pharmaceuticals Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Anal Cancer
- 10.2.4 Anal Cancer Product Introduction
- 10.2.5 Spectrum Pharmaceuticals Recent Development
- 10.3 Hospira
- 10.3.1 Hospira Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Anal Cancer
- 10.3.4 Anal Cancer Product Introduction
- 10.3.5 Hospira Recent Development
- 10.4 Global BioPharma
- 10.4.1 Global BioPharma Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Anal Cancer
- 10.4.4 Anal Cancer Product Introduction
- 10.4.5 Global BioPharma Recent Development
- 10.5 Advaxis
- 10.5.1 Advaxis Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Anal Cancer
- 10.5.4 Anal Cancer Product Introduction
- 10.5.5 Advaxis Recent Development
- 10.6 Amgen Inc
- 10.6.1 Amgen Inc Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Anal Cancer
- 10.6.4 Anal Cancer Product Introduction
- 10.6.5 Amgen Inc Recent Development
- 10.7 Atara Biotherapeutics
- 10.7.1 Atara Biotherapeutics Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Anal Cancer
- 10.7.4 Anal Cancer Product Introduction
- 10.7.5 Atara Biotherapeutics Recent Development
- 10.8 Bayer
- 10.8.1 Bayer Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Anal Cancer
- 10.8.4 Anal Cancer Product Introduction
- 10.8.5 Bayer Recent Development
- 10.9 Cell Medica
- 10.9.1 Cell Medica Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Anal Cancer
- 10.9.4 Anal Cancer Product Introduction
- 10.9.5 Cell Medica Recent Development
- 10.10 Eli Lilly
- 10.10.1 Eli Lilly Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Anal Cancer
- 10.10.4 Anal Cancer Product Introduction
- 10.10.5 Eli Lilly Recent Development
- 10.11 Genticel
- 10.12 ISA Pharmaceuticals
- 10.13 Merck＆Co
- 10.14 Millennium Pharmaceuticals
- 10.15 Novartis
- 10.16 Ono Pharmaceutical
- 10.17 Oryx
- 10.18 PDS Biotechnology
- 10.19 Sun Pharma
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Anal Cancer Sales Channels
- 11.2.2 Anal Cancer Distributors
- 11.3 Anal Cancer Customers
12 Market Forecast
- 12.1 Global Anal Cancer Sales and Revenue Forecast 2019-2025
- 12.2 Global Anal Cancer Sales Forecast by Type
- 12.3 Global Anal Cancer Sales Forecast by Application
- 12.4 Anal Cancer Forecast by Regions
- 12.4.1 Global Anal Cancer Sales Forecast by Regions 2019-2025
- 12.4.2 Global Anal Cancer Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Anal Cancer. Industry analysis & Market Report on Anal Cancer is a syndicated market report, published as Global (United States, European Union and China) Anal Cancer Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Anal Cancer market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
